Ying Cheng
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
- Oncology 20
- Lung Cancer Research Studies 8
- Colorectal Cancer Treatments and Studies 6
- HER2/EGFR in Cancer Research 5
-
- Epigenetics and DNA Methylation 3
- Co-authors
- Yi Qu (3 shared papers)Jin Li (2 shared papers)Xingzhen Zhang (2 shared papers)Ningli Wang (9 shared papers)Manyu Luo (1 shared paper)Hongge Wang (1 shared paper)Yi Qu (2 shared papers)Lining Miao (1 shared paper)
- Journals
- Journal of Clinical Oncology (13 papers)Journal of Thoracic Oncology (3 papers)Annals of Oncology (3 papers)Experimental Eye Research (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ying Cheng
41 papers receiving 628 citations
Peers
Comparison fields: 5 of 71
- Ophthalmology 121
- Cancer Research 147
- Pharmaceutical Science 58
- Hepatology 66
- Oncology 104
Countries citing papers authored by Ying Cheng
This map shows the geographic impact of Ying Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Cheng more than expected).
Fields of papers citing papers by Ying Cheng
This network shows the impact of papers produced by Ying Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Cheng. The network helps show where Ying Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 93 | |
| 2 | 2013 | 67 | |
| 3 | 2019 | 54 | |
| 4 | 2018 | 41 | |
| 5 | 2020 | 36 | |
| 6 | 2019 | 36 | |
| 7 | 2016 | 34 | |
| 8 | 2019 | 33 | |
| 9 | 2018 | 28 | |
| 10 | 2020 | 22 | |
| 11 | 2022 | 21 | |
| 12 | 2017 | 19 | |
| 13 | 2017 | 17 | |
| 14 | 2017 | 17 | |
| 15 | 2023 | 16 | |
| 16 | 2017 | 14 | |
| 17 | 2022 | 14 | |
| 18 | 2018 | 8 | |
| 19 | 2019 | 7 | |
| 20 | 2023 | 6 |
About Ying Cheng
Ying Cheng is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Ophthalmology and Radiology, Nuclear Medicine and Imaging, having authored 52 papers that have together received 635 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (8 papers), Retinal Diseases and Treatments (8 papers), Lung Cancer Treatments and Mutations (8 papers), Glaucoma and retinal disorders (7 papers), Colorectal Cancer Treatments and Studies (6 papers), HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Ophthalmology (121 citations), Cancer Research (147 citations), Pharmaceutical Science (58 citations), Hepatology (66 citations) and Oncology (104 citations). Ying Cheng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yi Qu, Jin Li, Xingzhen Zhang, Yi Qu, Ningli Wang, Manyu Luo, Hongge Wang, Yi Qu, Lining Miao and Rujia Li. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Experimental Eye Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.